Loading…
Pharmahub (ფარმაჰაბი) — a short-lived Georgian pharmaceutical wholesaler/distributor (inferred from a thin ~8% gross margin in its main year and no consumer-facing presence). Reported revenue only for FY2020–2021 (~GEL 2–5.5m) and appears dormant thereafter.
| Line item | 2020 | 2021 | CAGR |
|---|---|---|---|
| Total Revenue | 2,113 | 5,471 | +158.9% |
| Total COGS | 1,384 | 5,046 | +264.5% |
| Gross Profit | 728 | 425 | -41.7% |
| Gross Margin | 34.5% | 7.8% | |
| 9 | 605 | nmf | |
| EBITDA | 719 | 1,030 | +43.2% |
| EBITDA Margin | 34.0% | 18.8% | |
| Total D&A | 0 | 1 | |
| EBIT / Operating Income | 719 | 1,029 | +43.2% |
| Total Interest Expense | 21 | 3 | -87.9% |
| 0 | 700 | nmf | |
| Profit Before Tax | 698 | 1,727 | +147.3% |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 698 | 1,085 | +55.4% |
| Net Margin | 33.0% | 19.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →